Please login to the form below

Not currently logged in
Email:
Password:

New board member for Oxford Genome Sciences

Cancer-focused, UK-based genomics company Oxford Genome Sciences has asked Christopher Hibberd to join its board of directors.

Cancer-focused, UK-based genomics company Oxford Genome Sciences (OGeS) has asked Christopher Hibberd to join its board of directors.

The addition of Hibberd is due to his experience in business strategy and corporate development, specifically for the identification of strategic business opportunities in the areas of mergers, acquisitions, partnerships and alliances.

Hibberd is currently working as CEO of Astute Medical and prior to that worked for 10 years at Biosite, as senior vice-president of corporate development. OGeS partners with Biosite in the development of diagnostics for cancer based on OGeS' OGAP protein database.

Prior to Biosite, Hibberd was manager at Boston Consulting Group and was responsible for leading international consultants and client case teams in developing and implementing value-creating strategies for businesses in a variety of industry sectors.

Dr Christian Rohlff, CEO of OGeS, said: "I am very pleased to welcome Christopher to OGeS' Board of Directors. I am confident that his broad expertise will be valuable to support OGeS' corporate development at a time when we are transitioning from target discovery to building our own product pipeline of therapeutic antibodies."

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics